Company Filing History:
Years Active: 2025
Title: The Innovations of Riley Walsh
Introduction
Riley Walsh is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in immune response.
Latest Patents
Riley holds a patent for "Anti-TREM2 antibodies and methods of use thereof." This patent describes antibodies that specifically bind to the human triggering receptor expressed on myeloid cells 2 (TREM2) protein. In various embodiments, these antibodies can decrease levels of soluble TREM2 (sTREM2) and enhance TREM2 activity, showcasing their potential therapeutic applications.
Career Highlights
Riley is currently employed at Denali Therapeutics Inc., where he continues to advance his research and development efforts. His work focuses on innovative solutions that could lead to breakthroughs in treating neurodegenerative diseases.
Collaborations
Riley collaborates with notable colleagues, including Mark S. Dennis and Sherie Duncan, who contribute to the dynamic research environment at Denali Therapeutics Inc.
Conclusion
Riley Walsh's contributions to biotechnology through his patent on Anti-TREM2 antibodies exemplify the innovative spirit of modern inventors. His work has the potential to impact the treatment of various diseases, highlighting the importance of continued research and collaboration in the field.